Methicillin-resistant Staphylococcus aureus (MRSA): Burden of disease and control challenges in Europe

Eurosurveillance

Volumn 15, Issue 41, 2010, Pages 1-9

  Kock R ^a   Becker, K ^a   Cookson, B ^b   van Gemert Pijnen, J E ^c   Harbarth, S ^d,e   Kluytmans, J ^f,g   Mielke, M ^h   Peters, G ^a   Skov, R L ⁱ   Struelens, M J ^j,k   Tacconelli, E ^l   Torné, A Navarro ^k   Witte, W ^h   Friedrich, A W ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

^c UNIVERSITY OF TWENTE   (Netherlands)

^d GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^e UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^f VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^g AMPHIA HOSPITAL   (Netherlands)

^h ROBERT KOCH INSTITUTE   (Germany)

ⁱ STATENS SERUM INSTITUT   (Denmark)

^j ERASME HOSPITAL   (Belgium)

^k EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

^l CATHOLIC UNIVERSITY   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; METICILLIN; PENICILLIN DERIVATIVE; TETRACYCLINE; VANCOMYCIN;

ANIMAL DISEASE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIUM CONTAMINATION; BLOODSTREAM INFECTION; COMMUNICABLE DISEASE; DISEASE SURVEILLANCE; ENDEMIC DISEASE; EUROPE; EUROPEAN UNION; HEALTH CARE NEED; HOSPITAL INFECTION; HUMAN; INCIDENCE; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RISK; LIVESTOCK; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MORTALITY; NONHUMAN; PREVENTIVE HEALTH SERVICE; PUBLIC HEALTH PROBLEM; REVIEW; ANIMAL; BACTEREMIA; CROSS INFECTION; ECONOMICS; HEALTH SURVEY; HOSPITAL COST; LENGTH OF STAY; MICROBIOLOGY; RISK FACTOR; STAPHYLOCOCCUS INFECTION;

ANIMALS; BACTEREMIA; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; EUROPE; HOSPITAL COSTS; HUMANS; LENGTH OF STAY; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; POPULATION SURVEILLANCE; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS;

EID: 78049512867     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/ese.15.41.19688-en     Document Type: Review

References (87)

1. Council of the European Union. Council recommendation of 9 June 2009 on patient safety, including the prevention and control of healthcare-associated infections (2009/C151/01). Official Journal of the European Union. 3 Jul 2009. Available from: http://ec.europa.eu/health/patient_safety/docs/council_2009_en.pdf
2. European Centre for Disease Prevention and Control/European Medicines Agency (ECDC/EMEA). Joint technical report The bacterial challenge: time to react. Stockholm:ECDC/EMEA; 2009. Available from: http://www.ecdc.europa.eu/en/publications/Publications/0909_TER_The_Bacterial_Challenge_Time_to_React.pdf
3. Deurenberg RH, Vink C, Kalenic S, Friedrich AW, Bruggeman CA, Stobberingh EE. The molecular evolution of methicillinresistant Staphylococcus aureus. Clin Microbiol Infect. 2007;13(3):222-35.
4. Nemati M, Hermans K, Lipinska U, Denis O, Deplano A, Struelens M, et al. Antimicrobial resistance of old and recent Staphylococcus aureus isolates from poultry: first detection of livestock-associated methicillin-resistant strain ST398. Antimicrob Agents Chemother. 2008;52(10):3817-9.
5. Moore CL, Hingwe A, Donabedian SM, Perri MB, Davis SL, Haque NZ, et al. Comparative evaluation of epidemiology and outcomes of methicillin-resistant Staphylococcus aureus (MRSA) USA300 infections causing community- and healthcare-associated infections. Int J Antimicrob Agents. 2009;34(2):148-55.
6. Skov RL, Jensen KS. Community-associated meticillin-resistant Staphylococcus aureus as a cause of hospital-acquired infections. J Hosp Infect. 2009;73(4):364-70.
7. van Rijen MM, Van Keulen PH, Kluytmans JA. Increase in a Dutch hospital of methicillin-resistant Staphylococcus aureus related to animal farming. Clin Infect Dis. 2008;46(2):261-3.
8. Wyllie DH, Crook DW, Peto TE. Mortality after Staphylococcus aureus bacteremia in two hospitals in Oxfordshire, 1997-2003: cohort study. BMJ. 2006;333(7562):281.
9. Stamm AM, Long MN, Belcher B. Higher overall nosocomial infection rate because of increased attack rate of methicillinresistant Staphylococcus aureus. Am J Infect Control. 1993;21(2):70-4.
10. Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis. 2003;36(1):53-9.
11. Whitby M, McLaws ML, Berry G. Risk of death from methicillinresistant Staphylococcus aureus bacteremia: a meta-analysis. Med J Aust. 2001;175(5):264-7.
12. Wang F, Chen YY, Chen TL, Liu CY. Risk factors and mortality in patients with nosocomial Staphylococcus aureus bacteremia. Am J Infect Control. 2008;36(2):118-22.
13. Blot SI, Vandewoude KH, Hoste EA, Colardyn FA. Outcome and attributable mortality in critically Ill patients with bacteremia involving methicillin-susceptible and methicillinresistant Staphylococcus aureus. Arch Intern Med. 2002;162(19):2229-35.
14. Melzer M, Eykyn SJ, Gransden WR, Chinn S. Is methicillinresistant Staphylococcus aureus more virulent than methicillinsusceptible S. aureus? A comparative cohort study of British patients with nosocomial infection and bacteremia. Clin Infect Dis. 2003;37(11):1453-60.
15. Shurland S, Zhan M, Bradham DD, Roghmann M. Comparison of mortality risk associated with bacteremia due to methicillinresistant and methicillin-susceptible Staphylococcus aureus. Infect Control Hosp Epidemiol. 2007;28(3):273-9.
16. Reed SD, Friedman JY, Engemann JJ, Griffiths RI, Anstrom KJ, Kaye KS, et al. Costs and outcomes among hemodialysisdependent patients with methicillin-resistant or methicillinsusceptible Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol. 2005;26(2):175-83.
17. Talon D, Woronoff-Lemsi MC, Limat S, Bertrand X, Chatillon M, Gil H, et al. The impact of resistance to methicillin in Staphylococcus aureus bacteremia on mortality. Eur J Intern Med. 2002;13(1):31-36.
18. Cosgrove SE, Qi Y, Kaye KS, Harbarth S, Karchmer AW, Carmeli Y. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol. 2005;26(2):166-74.
19. Gastmeier P, Sohr D, Geffers C, Behnke M, Daschner F, Ruden H. Mortality risk factors with nosocomial Staphylococcus aureus infections in intensive care units: results from the German Nosocomial Infection Surveillance System (KISS). Infection. 2005;33(2):50-5.
20. Lodise TP, McKinnon PS. Clinical and economic impact of methicillin resistance in patients with Staphylococcus aureus bacteremia. Diagn Microbiol Infect Dis. 2005;52(2):113-22.
21. Guilarde AO, Turchi MD, Martelli CMT, Primo MG. Staphylococcus aureus bacteremia: incidence, risk factors and predictors for death in a Brazilian teaching hospital. J Hosp Infect. 2006;63(3):330-6.
22. Wang JL, Chen SY, Wang JT, Wu GH, Chiang WC, Hsueh PR, et al. Comparison of both clinical features and mortality risk associated with bacteremia due to community-acquired methicillin-resistant Staphylococcus aureus and methicillinsusceptible S. aureus. Clin Infect Dis. 2008;46(6):799-806.
23. Libert M, Elkholti M, Massaut J, Karmali R, Mascart G, Cherifi S. Risk factors for meticillin resistance and outcome of Staphylococcus aureus bloodstream infection in a Belgian university hospital. J Hosp Infect. 2008;68(1):17-24.
24. Rieg S, Peyerl-Hoffmann G, de With K, Theilacker C, Wagner D, Hubner J, et al. Mortality of S. aureus bacteremia and infectious diseases specialist consultation--a study of 521 patients in Germany. J Infect. 2009;59(4):232-9.
25. Malani PN, Rana MM, Banerjee M, Bradley SF. Staphylococcus aureus bloodstream infections: the association between age and mortality and functional status. J Am Geriatr Soc. 2008;56(8):1485-9.
26. Engemann JJ, Carmeli Y, Cosgrove SE, Fowler VG, Bronstein MZ, Trivette SL, et al. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis. 2003;36(5):592-8.
27. Ben-David D, Novikov I, Mermel LA. Are there differences in hospital cost between patients with nosocomial methicillinresistant Staphylococcus aureus bloodstream infection and those with methicillin-susceptible S. aureus bloodstream infection? Infect Control Hosp Epidemiol. 2009;30(5):453-60.
28. Shorr AF, Tabak YP, Gupta V, Johannes RS, Liu LZ, Kollef MH. Morbidity and cost burden of methicillin-resistant Staphylococcus aureus in early onset ventilator-associated pneumonia. Crit Care. 2006;10(3):R97.
29. van Rijen MM, Kluytmans JA. Costs and benefits of the MRSA Search and Destroy policy in a Dutch hospital. Eur J Clin Microbiol Infect Dis. 2009;28(10):1245-52.
30. Datta R, Huang SS. Risk of infection and death due to methicillin-resistant Staphylococcus aureus in long-term carriers. Clin Infect Dis. 2008;47(2):176-81.
31. Huang SS, Platt R. Risk of methicillin-resistant Staphylococcus aureus infection after previous infection or colonization. Clin Infect Dis. 2003;36(3):281-5.
32. Suetens C, Niclaes L, Jans B, Verhaegen J, Schuermans A, Van Eldere J, et al. Methicillin-resistant Staphylococcus aureus colonization is associated with higher mortality in nursing home residents with impaired cognitive status. J Am Geriatr Soc. 2006;54(12):1854-60.
33. European Antimicrobial Resistance Surveillance System (EARSS). EARSS Annual Report 2008. Bilthoven:EARSS; 2009. [Accessed 14 Jun 2010]. Available from: http://www.rivm.nl/earss/Images/EARSS%202008_final_tcm61-65020.pdf
34. European Centre for Disease Prevention and Control (ECDC). Annual epidemiological report on communicable diseases in Europe 2009. Stockholm:ECDC; 2010. [Accessed 14 Jun 2010]. Available from: http://www.ecdc.europa.eu/en/publications/Publications/ 0910_SUR_Annual_Epidemiological_Report_on_Communicable_Diseases_in_Europe.pdf
35. Tenover FC, Goering RV. Methicillin-resistant Staphylococcus aureus strain USA300: origin and epidemiology. J Antimicrob Chemother. 2009;64(3):441-6.
36. Ellington MJ, Perry C, Ganner M, Warner M, McCormick S, Hill RL, et al. Clinical and molecular epidemiology of ciprofloxacinsusceptible MRSA encoding PVL in England and Wales. Eur J Clin Microbiol Infect Dis. 2009; 28(9):1113-21.
37. Diederen BM, Kluytmans JA. The emergence of infections with community-associated methicillin resistant Staphylococcus aureus. J Infect. 2006;52(3):157-68.
38. Denis O, Deplano A, De Beenhouwer H, Hallin M, Huysmans G, Garrino MG, et al. Polyclonal emergence and importation of community-acquired methicillin-resistant Staphylococcus aureus strains harbouring Panton-Valentine leucocidin genes in Belgium. J Antimicrob Chemother. 2005;56(6):1103-6.
39. Larsen AR, Stegger M, Goering R, Sørum M, Skov R. Emergence and dissemination of the methicillin resistant Staphylococcus aureus USA300 clone in Denmark (2000-2005). Euro Surveill. 2007;12(2):pii=682. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=682
40. Bocher S, Gervelmeyer A, Monnet DL, Molbak K, Skov RL, Danish CA-MRSA Study Group. Methicillin-resistant Staphylococcus aureus: risk factors associated with community-onset infections in Denmark. Clin Microbiol Infect. 2008;14(10):942-8.
41. Gillet Y, Issartel B, Vanhems P, Fournet JC, Lina G, Bes M, et al. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet. 2002;359(9308):753-9.
42. Witte W, Strommenger B, Cuny C, Heuck D, Nuebel U. Methicillin-resistant Staphylococcus aureus containing the Panton-Valentine leucocidin gene in Germany in 2005 and 2006. J Antimicrob Chemother. 2007;60(6):1258-63.
43. Manzur A, Dominguez AM, Pujol M, Gonzalez MP, Limon E, Hornero A, et al. Community-acquired methicillin-resistant Staphylococcus aureus infections: an emerging threat in Spain. Clin Microbiol Infect. 2008;14(4):377-80.
44. Bartels MD, Boye K, Rhod Larsen A, Skov R, Westh H. Rapid increase of genetically diverse methicillin-resistant Staphylococcus aureus, Copenhagen, Denmark. Emerg Infect Dis. 2007;13(10):1533-40.
45. Ruppitsch W, Stoger A, Schmid D, Fretz R, Indra A, Allerberger F, et al. Occurrence of the USA300 community-acquired Staphylococcus aureus clone in Austria. Euro Surveill. 2007;12(10):E071025.1.
46. Goering RV, Larsen AR, Skov R, Tenover FC, Anderson KL, Dunman PM. Comparative genomic analysis of European and Middle Eastern community-associated methicillin-resistant Staphylococcus aureus (CC80:ST80-IV) isolates by highdensity microarray. Clin Microbiol Infect. 2009; 15(8):748-55.
47. Larsen AR, Stegger M, Bocher S, Sorum M, Monnet DL, Skov RL. Emergence and characterization of community-associated methicillin-resistant Staphyloccocus aureus infections in Denmark, 1999 to 2006. J Clin Microbiol. 2009;47(1):73-8.
48. Fang H, Hedin G, Li G, Nord CE. Genetic diversity of communityassociated methicillin-resistant Staphylococcus aureus in southern Stockholm, 2000-2005. Clin Microbiol Infect. 2008;14(4):370-6.
49. Marchese A, Gualco L, Maioli E, Debbia E. Molecular analysis and susceptibility patterns of meticillin-resistant Staphylococcus aureus (MRSA) strains circulating in the community in the Ligurian area, a northern region of Italy: emergence of USA300 and EMRSA-15 clones. Int J Antimicrob Agents. 2009;34(5):424-8.
50. Jappe U, Heuck D, Strommenger B, Wendt C, Werner G, Altmann D, et al. Staphylococcus aureus in dermatology outpatients with special emphasis on community-associated methicillinresistant strains. J Invest Dermatol. 2008;128(11):2655-64.
51. Thibaut S, Caillon J, Huart C, Grandjean G, Lombrail P, Potel G, et al. Susceptibility to the main antibiotics of Escherichia coli and Staphylococcus aureus strains identified in community acquired infections in France (MedQual, 2004-2007). Med Mal Infect. 2010;40(2):74-80.
52. Vourli S, Vagiakou H, Ganteris G, Orfanidou M, Polemis M, Vatopoulos A, et al. High rates of community-acquired, Panton- Valentine leukocidin (PVL)- positive methicillin-resistant S. aureus (MRSA) infections in adult outpatients in Greece. EuroSurveill. 2009;14(2):pii=19089. Available from: http://www. eurosurveillance.org/ViewArticle.aspx?ArticleId=19089
53. European Food Safety Authority (EFSA). Analysis of the baseline survey on the prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in holdings with breeding pigs, in the EU, 2008 - Part A: MRSA prevalence estimates. EFSA Journal 2009;7(11):1376.
54. Bosch T, de Neeling AJ, Schouls LM, van der Zwaluw KW, Kluytmans JA, Grundmann H, et al. PFGE diversity within the methicillin-resistant Staphylococcus aureus clonal lineage ST398. BMC Microbiol. 2010;10:40.
55. Monecke S, Kuhnert P, Hotzel H, Slickers P, Ehricht R. Microarray based study on virulence-associated genes and resistance determinants of Staphylococcus aureus isolates from cattle. Vet Microbiol. 2007;125(1-2):128-40.
56. Schwarz S, Kadlec K, Strommenger B. Methicillin-resistant Staphylococcus aureus and Staphylococcus pseudintermedius detected in the BfT-GermVet monitoring programme 2004-2006 in Germany. J Antimicrob Chemother. 2008;61(2):282-5.
57. Cuny C, Strommenger B, Witte W, Stanek C. Clusters of infections in horses with MRSA ST1, ST254, and ST398 in a veterinary hospital. Microb Drug Resist. 2008;14(4):307-10.
58. Voss A, Loeffen F, Bakker J, Klaassen C, Wulf M. Methicillinresistant Staphylococcus aureus in pig farming. Emerg Infect Dis. 2005;11(12):1965-6.
59. Denis O, Suetens C, Hallin M, Catry B, Ramboer I, Dispas M, et al. Methicillin-resistant Staphylococcus aureus ST398 in swine farm personnel, Belgium. Emerg Infect Dis. 2009;15(7):1098-101.
60. Cuny C, Nathaus R, Layer F, Strommenger B, Altmann D, Witte W. Nasal colonization of humans with methicillin-resistant Staphylococcus aureus (MRSA) CC398 with and without exposure to pigs. PLoS One. 2009;4(8):e6800.
61. Köck R, Harlizius J, Bressan N, Laerberg R, Wieler LH, Witte W, et al. Prevalence and molecular characteristics of methicillinresistant Staphylococcus aureus (MRSA) among pigs on German farms and import of livestock-related MRSA into hospitals. Eur J Clin Microbiol Infect Dis. 2009;28(11):1375-82.
62. Wulf MW, Markestein A, van der Linden FT, Voss A, Klaassen C, Verduin CM. First outbreak of methicillin-resistant Staphylococcus aureus ST398 in a Dutch hospital, June 2007. Euro Surveill. 2008;13(9):pii=8051. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=8051
63. Ekkelenkamp MB, Sekkat M, Carpaij N, Troelstra A, Bonten MJM. [[Endocarditis due to meticillin-resistant Staphylococcus aureus originating from pigs]. Ned Tijdschr Geneeskd. 2006;150(44):2442-7. Dutch.
64. Pan A, Battisti A, Zoncada A, Bernieri F, Boldini M, Franco A, et al. Community-acquired methicillin-resistant Staphylococcus aureus ST398 infection, Italy. Emerg Infect Dis. 2009;15(5):845-7.
65. Witte W, Strommenger B, Stanek C, Cuny C. Methicillinresistant Staphylococcus aureus ST398 in humans and animals, Central Europe. Emerg Infect Dis. 2007;13(2):255-8.
66. Dutch Working Party on Antibiotic Policy (SWAB). NethMap 2008, Consumption of antimicrobial agents and antimicrobial resistance among medically important bacteria in the Netherlands, 2009. Amsterdam:SWAB. [Accessed 14 Jun 2010]. Available from: http://www.swab.nl/swab/cms3.nsf/uploads/6E11368E7BB72739C12575940049664D/$FILE/NethMap_2008.pdf
67. Welinder-Olsson C, Floren-Johansson K, Larsson L, Oberg S, Karlsson L, Ahren C. Infection with Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus t034. Emerg Infect Dis. 2008;14(8):1271-2.
68. Kehrenberg C, Cuny C, Strommenger B, Schwarz S, Witte W. Methicillin-resistant and -susceptible Staphylococcus aureus strains of clonal lineages ST398 and ST9 from swine carry the multidrug resistance gene cfr. Antimicrob Agents Chemother. 2009;53(2):779-81.
69. de Boer E, Zwartkruis-Nahuis JT, Wit B, Huijsdens; XW, de Neeling AJ, Bosch T, et al. Prevalence of methicillin-resistant Staphylococcus aureus in meat. Int J Food Microbiol. 2009; 134(1-2):52-6.
70. Jones TF, Kellum ME, Porter SS, Bell M, Schaffner W. An outbreak of community-acquired foodborne illness caused by methicillin-resistant Staphylococcus aureus. Emerg Infect Dis. 2002;8(1):82-4.
71. Kluytmans J, van Leeuwen W, Goessens W, Hollis R, Messer S, Herwaldt L, et al. Food-initiated outbreak of methicillinresistant Staphylococcus aureus analyzed by pheno- and genotyping. J Clin Microbiol. 1995;33(5):1121-8.
72. Carlet J, Astagneau P, Brun-Buisson C, Coignard B, Salomon V, Tran B, et al. French national program for prevention of healthcare-associated infections and antimicrobial resistance, 1992-2008: positive trends, but perseverance needed. Infect Control Hosp Epidemiol. 2009;30(8):737-45.
73. Scientific Institute of Public Health. National Surveillance of Hospital Infections (NSIH). National Surveillance of Nosocomial Septicemia (Hospital-wide). National Analysis. Data from 1/01/2008 to 31/12/2008. Brussels: NSIH; 30 Jun 2009. Available from: http://www.iph.fgov.be/nsih/download/SEP/sBelg_2008_data.pdf.
74. Conseil Supérieur d' Hygiène. Guidelines for the control and prevention of methicillin-resistant Staphylococcus aureus transmission in Belgian hospitals [Accessed 14 Jun 2010]. Available from: https://portal.health.fgov.be/pls/portal/docs/PAGE/INTERNET_PG/HOMEPAGE_MENU/ABOUTUS1_MENU/INSTITUTIONSAPPARENTEES1_MENU/HOGEGEZONDHEIDSRAAD1_MENU/ADVIEZENENAANBEVELINGEN1_MENU/ADVIEZENENAANBEVELINGEN1_DOCS/7725%20MRSA%20EN%202003.PDF
75. Goossens H, Coenen S, Costers M, De Corte S, De Sutter A, Gordts B, et al. Achievements of the Belgian Antibiotic Policy Coordination Committee (BAPCOC). Euro Surveill. 2008;13(46):pii=19036. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19036
76. Department of Health (DH) [Internet]. London:DH. [Accessed 14 Jun 2010]. Available from: http://www.dh.gov.uk
77. Health Protection Agency (HPA). Healthcare-associated Infections in England: 2008-2009 Report. London:HPA; Reviewed 10 Sept 2009. [Accessed 14 Oct 2010]. Available from: http://www.hpa.org.uk/web/HPAwebFile/HPAweb_C/1252326222452
78. Denis O, Jans B, Deplano A, Nonhoff C, De Ryck R, Suetens C, et al. Epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) among residents of nursing homes in Belgium. J Antimicrob Chemother. 2009;64(6):1299-306.
79. von Baum H, Schmidt C, Svoboda D, Bock-Hensley O, Wendt C. Risk factors for methicillin-resistant Staphylococcus aureus carriage in residents of German nursing homes. Infect Control Hosp Epidemiol. 2002;23(9):511-5.
80. Manzur A, Gavalda L, Ruiz de Gopegui E, Mariscal D, Dominguez MA, Perez JL, et al. Prevalence of methicillinresistant Staphylococcus aureus and factors associated with colonization among residents in community long-term-care facilities in Spain. Clin Microbiol Infect. 2008;14(9):867-72.
81. Eveillard M, Charru P, Rufat P, Hippeaux M, Lancien E, Benselama F, et al. Methicillin-resistant Staphylococcus aureus carriage in a long-term care facility: hypothesis about selection and transmission. Age Ageing. 2008;37(3):294-9.
82. Cox RA, Bowie PE. Methicillin-resistant Staphylococcus aureus colonization in nursing home residents: a prevalence study in Northamptonshire. J Hosp Infect. 1999;43(2):115-22.
83. Baldwin NS, Gilpin DF, Hughes CM, Kearney MP, Gardiner DA, Cardwell C, et al. Prevalence of methicillin-resistant Staphylococcus aureus colonization in residents and staff in nursing homes in Northern Ireland. J Am Geriatr Soc. 2009;57(4):620-6.
84. Ahearn DJ, Jackson TB, McIlmoyle J, Weatherburn AJ. Improving end of life care for nursing home residents: an analysis of hospital mortality and readmission rates. Postgrad Med J. 2010;86(1013):131-5.
85. Manzur A, Gudiol F. Methicillin-resistant Staphylococcus aureus in long-term-care facilities. Clin Microbiol Infect. 2009;15 (Suppl 7)(26-30).
86. D'Agata EM, Webb GF, Horn MA, Moellering RC Jr., Ruan S. Modeling the invasion of community-acquired methicillinresistant Staphylococcus aureus into hospitals. Clin Infect Dis. 2009;48(3):274-84.
87. Webb GF, Horn MA, D'Agata EM, Moellering RC, Ruan S. Competition of hospital-acquired and community-acquired methicillin-resistant Staphylococcus aureus strains in hospitals. J Biol Dyn. 2009;48:271.